{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:49:58Z","timestamp":1793508598480,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"NIA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.neurobiolaging.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T16:20:23Z","timestamp":1613060423000},"page":"64-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Cognitively normal APOE \u03b54 carriers have specific elevation of CSF SNAP-25"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2252-3673","authenticated-orcid":false,"given":"Omar H.","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0769-604X","authenticated-orcid":false,"given":"Justin M.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0664-0629","authenticated-orcid":false,"given":"Rachel L.","family":"Henson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Herries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney L.","family":"Sutphen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack H.","family":"Ladenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau M.","family":"Ances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-1465","authenticated-orcid":false,"given":"Suzanne E.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0001","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1073\/pnas.0812697106","article-title":"Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia","volume":"106","author":"Agosta","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0002","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2019.01.004","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum","volume":"15","author":"Bos","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2021.02.008_bib0003","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1750-1326-9-53","article-title":"SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease","volume":"9","author":"Brinkmalm","year":"2014","journal-title":"Mol Neurodegener"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0004","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00005072-199710000-00004","article-title":"Dendritic translocation of RC3\/neurogranin mRNA in normal aging, Alzheimer disease and fronto-temporal dementia","volume":"56","author":"Chang","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"issue":"26","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0005","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0006","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","article-title":"GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease","volume":"78","author":"Cruchaga","year":"2013","journal-title":"Neuron."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0007","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jalz.2015.05.012","article-title":"C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease","volume":"11","author":"De Vos","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0008","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/jnc.13417","article-title":"Apolipoprotein E4 reduces evoked hippocampal acetylcholine release in adult mice","volume":"136","author":"Dolej\u0161\u00ed","year":"2016","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1471-4159.2012.07908.x","article-title":"APOE genotype affects the pre-synaptic compartment of glutamatergic nerve terminals","volume":"124","author":"Dumanis","year":"2013","journal-title":"J Neurochem"},{"issue":"48","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0010","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo","volume":"29","author":"Dumanis","year":"2009","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0011","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2012.04.017","article-title":"Apolipoprotein E \u03b54 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease","volume":"34","author":"Fleisher","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2021.02.008_bib0013","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.trci.2019.11.002","article-title":"Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease","volume":"5","author":"Galasko","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0014","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0015","doi-asserted-by":"crossref","first-page":"e59478","DOI":"10.1371\/journal.pone.0059478","article-title":"Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development","volume":"8","author":"Jain","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0016","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2018.3459","article-title":"Association of cerebrospinal fluid neurofilament light protein with risk of mild cognitive impairment among individuals without cognitive impairment","volume":"76","author":"Kern","year":"2019","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0017","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaneurol.2015.1867","article-title":"Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease","volume":"72","author":"Kester","year":"2015","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0018","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0019","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuroscience.2010.10.027","article-title":"Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2","volume":"171","author":"Klein","year":"2010","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0020","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0021","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.21696","article-title":"Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age","volume":"65","author":"Kok","year":"2009","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0022","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease","volume":"11","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0023","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-015-0124-3","article-title":"Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls","volume":"7","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0024","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0969-9961(03)00045-7","article-title":"ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory","volume":"13","author":"Levi","year":"2003","journal-title":"Neurobiol Dis"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0025","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1212\/01.WNL.0000128089.53030.AC","article-title":"Apolipoprotein E controls the risk and age at onset of Parkinson disease","volume":"62","author":"Li","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0026","doi-asserted-by":"crossref","first-page":"17368","DOI":"10.1038\/s41598-018-35766-w","article-title":"Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease","volume":"8","author":"Lin","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0027","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0028","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","article-title":"ApoE4 accelerates early seeding of amyloid pathology","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0029","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.neurobiolaging.2005.04.008","article-title":"Premorbid effects of APOE on synaptic proteins in human temporal neocortex","volume":"27","author":"Love","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/NEN.0b013e3181a9d503","article-title":"Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury","volume":"68","author":"McKee","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0031","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0032","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0033","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamaneurol.2018.4249","article-title":"Assessment of racial disparities in biomarkers for Alzheimer disease","volume":"76","author":"Morris","year":"2019","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0034","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0035","doi-asserted-by":"crossref","first-page":"e00134","DOI":"10.1042\/AN20130043","article-title":"ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro","volume":"6","author":"Nwabuisi-Heath","year":"2014","journal-title":"ASN Neuro"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0036","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000093867","article-title":"A study of potential interactive genetic factors in Huntington's disease","volume":"55","author":"Panegyres","year":"2006","journal-title":"Eur Neurol"},{"issue":"Pt 11","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0037","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1093\/brain\/awv267","article-title":"Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease","volume":"138","author":"Portelius","year":"2015","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0038","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jalz.2018.01.013","article-title":"Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging","volume":"14","author":"Schindler","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0039","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1084\/jem.20190980","article-title":"Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model","volume":"216","author":"Shi","year":"2019","journal-title":"J Exp Med"},{"issue":"7673","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0041","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/j.2040-4603.2014.tb00546.x","article-title":"Exocytosis and synaptic vesicle function","volume":"4","author":"Shin","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/j.neurobiolaging.2021.02.008_bib0042","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroimage.2014.11.058","article-title":"Dominantly Inherited Alzheimer Network, 2015. Partial volume correction in quantitative amyloid imaging","volume":"107","author":"Su","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2021.02.008_bib0043","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nicl.2018.04.022","article-title":"Utilizing the centiloid scale in cross-sectional and longitudinal PiB PET studies","volume":"19","author":"Su","year":"2018","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurobiolaging.2021.02.008_bib0044","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.dadm.2018.12.008","article-title":"Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies","volume":"11","author":"Su","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0045","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jalz.2018.01.012","article-title":"Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease","volume":"14","author":"Sutphen","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0046","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuint.2006.05.004","article-title":"Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4","volume":"49","author":"Tannenberg","year":"2006","journal-title":"Neurochem Int"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0047","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease","volume":"73","author":"Tarawneh","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.02.008_bib0048","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2010.09.073","article-title":"Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease","volume":"1362","author":"Thorsell","year":"2010","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0049","doi-asserted-by":"crossref","first-page":"e953","DOI":"10.1212\/WNL.0000000000010131","article-title":"Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease","volume":"95","author":"Tible","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0050","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.nbd.2004.10.013","article-title":"Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology","volume":"18","author":"Wang","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurobiolaging.2021.02.008_bib0051","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fnagi.2018.00383","article-title":"Levels of cortisol in CSF are associated with SNAP-25 and tau pathology but not amyloid-\u03b2","volume":"10","author":"Wang","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neurobiolaging.2021.02.008_bib0052","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2018.08.029","article-title":"APOE \u03b54 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease","volume":"685","author":"Wang","year":"2018","journal-title":"Neurosci Lett."},{"issue":"42","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0053","doi-asserted-by":"crossref","first-page":"39944","DOI":"10.1074\/jbc.M205147200","article-title":"Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning","volume":"277","author":"Weeber","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0054","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-018-0407-6","article-title":"Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease","volume":"10","author":"Zhang","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"529","key":"10.1016\/j.neurobiolaging.2021.02.008_bib0055","doi-asserted-by":"crossref","first-page":"eaay1809","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid","volume":"12","author":"Zhao","year":"2020","journal-title":"Sci Transl Med"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:38:20Z","timestamp":1759318700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":55,"alternative-id":["S0197458021000580"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.02.008","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitively normal APOE \u03b54 carriers have specific elevation of CSF SNAP-25","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}